Predictive Biomarkers of Severe Immune-Related Adverse Events With Immune Checkpoint Inhibitors: Prevention, Underlying Causes, Intensity, and Consequences. | Front Med (Lausanne);9: 908752, 2022. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Nursing VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Predictive Biomarkers of Severe Immune-Related Adverse Events With Immune Checkpoint Inhibitors: Prevention, Underlying Causes, Intensity, and Consequences.

Cardeña-Gutiérrez, Ana; López Barahona, Mónica.

Affiliation

Cardeña-Gutiérrez A; MedicalOncologyDepartment, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
López Barahona M; Centro Estudios Biosanitarios, Madrid, Spain.

Front Med (Lausanne) ; 9: 908752, 2022.

Article in En | MEDLINE | ID: mdl-35774996

Key words

autoimmunity; biomarker; immune checkpoint proteins; immune-related adverse event (irAE); severe toxicity

Search on Google

Full text: 1 Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Med (Lausanne) Year: 2022 Type: Article Affiliation country: Spain

Search on Google

Full text: 1 Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Med (Lausanne) Year: 2022 Type: Article Affiliation country: Spain